Equity Profile
Post-Earnings Recap
Axsome Therapeutics, Inc.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.83 | $0.81 | +2.85% |
| Revenue | N/A | $846M | N/A |
management commentary, guidance changes, and full analysis available with Pro.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Avient Corporation operates in the specialty chemicals sector, providing innovative solutions for various industries, including packaging, automotive, and consumer goods. With a market cap of $3 billion, Avient plays a crucial role in enhancing product performance and sustainability through its advanced materials and technologies.
EPS
Earnings per share (EPS) is a key indicator of the company's profitability and is closely watched by investors.
Revenue
Revenue figures provide insight into the company's sales performance and overall growth trajectory.
Wall Street expectations, options signals, track record, and call prep available with Pro.
Net buying
Recent Transactions
Traded Mar 3, 2026 · disclosed Apr 7, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.